Chacruna Institute for Psychedelic Plant Medicines is a registered California 501(c)(3) non-profit organization (EIN 84-3076078). We are a community-oriented organization run by a small staff of experts and enthusiastic volunteers who work to bring education and cultural understanding about psychedelic plant medicines to a wider audience. We promote a bridge between the ceremonial use of sacred plants and psychedelic science and envisage a world where plant medicines and other psychedelics are preserved, protected, and valued as part of our cultural identity and integrated into our social, legal, and health care systems.
Help us to achieve our mission! From our beginnings in 2017, we have stood apart from other psychedelic education and advocacy organizations by pioneering initiatives that support and provide a platform for diverse voices, including women, queer people, people of color, Indigenous people, and the Global South. In efforts to address the lack of diverse representation in the expanding psychedelic landscape, we centered our mission around the empowerment of marginalized voices to foster cultural and political reflections on topics like race, gender, and sexuality in psychedelic science. We believe now more than ever, given the current social and political climate, our work is critical to the future of psychedelic healing for humanity.
Please become a member so that you are able to help Chacruna, yourself, and the world. Support of any amount helps this cause and allows us to provide psychedelic education to anyone who wants to access it.
Dr.’s Aryan Sarparast, Chris Stauffer, Kelan Thomas, and Benjamin Malcolm, recently published the first systematic review of drug interactions between psychiatric medications and psychedelics: “Drug-drug interactions between psychiatric medications and MDMA or psilocybin: A systematic review.” In this article, the authors offer a synopsis of their systematic review.
The incredible states of consciousness that emerge when people consume the psychedelic molecule DMT are characterized by a multiplicity of features. DMT is able...
What is the connection between ayahuasca and epigenetics? In this study, the researchers explored whether ayahuasca could be used as a treatment for developmental trauma.
In clinical literature, psilocybin, DMT, and MDMA receive a great deal of attention, but, as Ana Camacho shows, the same is not true for the peyote cactus and mescaline. This article looks back on the history of the psychedelic substance in Western science to understand why it is not as popular today as it was during the mid-twentieth century.
The rise in popularity of peyote has unfortunately led to overharvesting which consequently poses a great risk for the future of the species. With the increasing need to protect peyote, synthetic mescaline may offer an alternative gateway into this experience that is bereft of issues regarding sustainability. This article summarizes the chemical composition and production of synthetic mescaline.
There is an alarming global decline in lncilus alvarius toad populations, the toads who secrete 5-MeO-DMT, because of multiple ecological reasons and the increased interest in toad ‘milking’ for psychedelic experiences. Anya Ermakova, Ph.D. educates the reader on the ecological impacts of these toad populations and provides alternative, synthetic options for psychonauts who would like to use 5-MeO-DMT.
The labeling of the psychedelic experience as ‘mystical’ may do little to improve public opinion about psychedelics, especially among those with traditional, conservative values. While it is no surprise that psychedelics can induce deep spiritual experiences, there is no scientific evidence that psychedelics can change one’s political or religious beliefs.